Amarin reported 1.04M in EBIT for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebit Change
Acceleron Pharma XLRN:US $ -70630000 6.97M
Adamas Pharmaceuticals ADMS:US -5636000 3.52M
Aerie Pharmaceuticals AERI:US $ -32374000 873K
Alnylam Pharmaceuticals ALNY:US $ -181677000 35.52M
Amarin AMRN:US 1.04M 7.73M
Arena Pharmaceuticals ARNA:US $ -124485000 19.91M
AstraZeneca AZN:LN -4000000 1.45B
Biocryst Pharmaceuticals BCRX:US $ -44584000 15M
Epizyme EPZM:US $ -64140000 5.91M
Esperion Therapeutics ESPR:US $ -55745000 23.21M
GlaxoSmithKline GSK:LN 2.67B 712M
Halozyme Therapeutics HALO:US $ 75.59M 17.46M
Intercept Pharmaceuticals ICPT:US $ -6218000 6.73M
JAZZ PHA JAZZ:US 28.37M 97.96M
Nektar Therapeutics NKTR:US $ -113596000 3.39M
Neurocrine Biosciences NBIX:US $ 44.5M 23.3M
Novartis NOVN:VX 3.48B 77M
Teva Pharmaceutical Industries TEVA:US 806M 23M